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Summary : The fecal enzymes originating from the injurious bacteria in the intestinal tract,
azoreductase and nitroreductase, convert pro-carcinogens to proximal carcinogens. The e#ect of
fermented milk on the activity of fecal enzymes in mice was studied. The fermented milk was
prepared using + low-fat milk with the starter of Lactobacillus gasseri JCM ++-* and Lactobacillus
amylovorus JCM /2++. Mice were fed with diets containing high contents of protein and fat. When
administered fermented milk as Lactobacillus strains supplement, the mice exhibited signiﬁcantly
lower levels of azoreductase and nitroreductase activities in the feces as compared with the levels of
their activities in the feces of nontreated mice. The number of viable lactic acid bacteria increased in
the mice feces for / days after the administration of fermented milk, and the same species of lactic acid
bacteria from fermented milk was detected in their feces by using random ampliﬁed polymorphic
DNA (RAPD) method.
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The incidence of colon cancer shows an increasing
trend in Japan. The role of diets with high contents of
protein and fat in the etiology of colon cancer has not
been well established. Changes in the metabolic activ-
ity of intestinal microﬂora could occur without appre-
ciable changes in the numbers or types of viable micro-
organisms in the gut. Bacteria possess many induc-
ible or repressible enzymes for colon cancer.
Nitroreductase and azoreductase from the injurious
bacteria in the intestinal tract produce nitroso- and N-
hydroxy compounds, which are well-known carcino-
gens. GOLDIN et al.+ reported that the supplementa-
tion of the normal diet of mice with Lactobacillus aci-
dophilus suppressed the activities of fecal nitro-
reductase, azoreductase and b-glucuronidase.
The recent development of PCR method using
genomic DNA for obtaining random ampliﬁed poly-
morphic DNA (RAPD) ﬁngerprints allows easy identi-
ﬁcation of lactic acid bacteria from foods or en-
vironmental and intestinal samples.
In this experiment, the e#ect of oral administration
of fermented milk on the activities of azoreductase and
nitroreductase, and the number of viable lactobacilli
and the detection of orally administered lactobacilli in
the mice feces were studied.
Materials and Methods
Animals and diets
Speciﬁc pathogen-free male C-H/Hen mice (/ weeks
old) were purchased from Japan SLC, Inc. (Shizuoka,
Japan). Mice were divided into three groups and ﬁve
mice were housed in each plastic cage. Group + mice
(experimental group) and group , mice (control group)
were fed with a diet of high protein and fat contents
(MR-A+, Nihon Nosan Kogyo K.K., Kanagawa, Japan).
Group - mice (normal group) were fed with a regular
diet (F-,, Funabashi Farms Co., Ltd., Chiba, Japan).
All mice were provided with tap water ad libitum.
Preparation of fermented milk
Lactobacillus gasseri JCM ++-* and Lactobacillus
amylovorus JCM /2++, were used for the fermented milk
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preparation. Two strains isolated from human feces
were kindly provided by Japan Collection of Microor-
ganisms (The Institute of Physical and Chemical Re-
search, Saitama, Japan). The strains were stored in
+* solid-reconstituted skim milk at 2*. They
were grown in +* solid-reconstituted skim milk for
+2,. hours at -1 under aerobic conditions. This
operation was continuously repeated three times prior
to use in the preparation of fermented milk. Two
actively grown Lactobacillus strains were added into /
ml of + low-fat milk. The milk was incubated for +0
+2 hours at -1 under aerobic condition. The result-
ing fermented milk (+*2 cfu/ml) was used after being
diluted with equal an volume of ultrapure water to
decrease the viscosity.
Schedules of oral administration
The fermented milk as lactobacilli supplement was
orally administered to group + mice in a dose of +*ml/
kg/day using a blunt tipped feeding needle for the ﬁrst
+* days (term I) and the last +* days (term III) of the
experimental period (1. days), however the mice were
not fed with the fermented milk for the middle /. days
(term II) between term I and term III. Group , and -
mice were not supplied with the fermented milk
throughout the experiment period.
Collection of fecal specimens and preparation of fecal
extract
The bedding of the mice was cleaned, and at 1 : **1
: -* am of the next day soft and fresh feces of the mice
were collected. The fecal specimens were assayed im-
mediately after collection.
The fresh fecal samples (+/*mg/ml) were suspended
in cold prereduced *.,M Tris-HCl bu#er (pH 1.2).
Glass beads (*.,mm diameter) were added to the fecal
suspension for complete homogenization. The sus-
pension was agitated in a tightly stoppered tube for /
minutes on a vortex mixer. After centrifugation at
,**g for +* minutes, the supernatant was used for the
enzyme assay.
Azoreductase assay
The speciﬁc activity of fecal azoreductase was deter-
mined by the modiﬁed method of GOLDIN et al,. All
solutions were prereduced. The enzyme reaction was
run anaerobically at -1 in a total volume of *./ml
consisting of *.,ml of +mM sunset yellow [+-(. sulfo-+
-phenylazo)-, -naphthol- 0 -sulfonic acid, +3+  ++*1,,
Wako, Japan] solution and *.-ml of fecal extract.
After , hours, the reaction was terminated by the addi-
tion of *.1/ml of +.,N HCl. The reaction mixture was
centrifuged at ,*,***g for -* minutes, and the
amounts of reduced products of sunset yellow in the
supernatant were measured by the BRATTON and
MARSHALL method-. The results were standardized by
calculating the amounts of reduced sunset yellow (mg/
hr/mg-fecal protein).
Nitroreductase assay
The speciﬁc activity of the fecal nitroreductase was
determined by the modiﬁed method of GOLDIN et al,.
All solutions were prereduced. The enzyme reaction
was run anaerobically at -1 in a total volume of +ml
consisting of *.,ml of +.1/mM m-nitrobenzoic acid solu-
tion, *.,ml of ,./mM NADPH (N-0/*/, Sigma, St. Louis,
MO, USA) solution, *.,ml of /mM NADH (N-2+,3,
Sigma) solution and *..ml of fecal extract. The
amount of m-aminobenzoic acid formed was then meas-
ured by the BRATTON and MARSHALL method-. The
results were standardized by calculating the amount of
m-aminobenzoic acid (mg/hr/mg-fecal protein).
Discrimination of the supplemented lactobacilli in
feces by RAPD method
The colonies of Lactobacillus were isolated from the
collected feces using BCP plate count agar (E-MB-+,
Eiken Chemical Co., Ltd., Tokyo, Japan). Ten individ-
ual colonies were picked up from the colonies formed
on BCP plate count agar and cultured in MRS broth
(Oxoid, Unipath Ltd, Hampshire, UK) for +0,* hours at
-1. The extraction of DNA from lactobacilli was
performed by the benzyl chloride method of HENG
et al.. PCR ampliﬁcation was performed in a Thermal
Cycler TP--*** (Takara Biomedicals, Tokyo, Japan)
using Takara EX TaqTM (RR**+A, Takara Biomedicals)
and three primers of arbitrary nucleotide sequences
(primer A : /  CCGCAGCCAA - , primer B : / 
AACGCGCAAC -, primer C : /GCGGAAATAG -)/.
The products of PCR were electrophoresesed on +./
agarose gel. After staining with + ethidium bromide
solution, the gels were photographed under UV light.
As control, the puriﬁed L. gasseri JCM ++-* and L.
gasseri JCM /2++ were used.
Number of viable lactic acid bacteria in the feces of
mice
The mice and fermented milk were used in this ex-
periment in the same manner as described above. The
mice were fed with a regular diet throughout the ex-
periment period. The fermented milk was ad-
ministered to the mice consecutively for - days using a
blunt tipped feeding needle. Fresh feces of mice were
collected +, -, / and +* days after the termination of the
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administration of fermented milk to mice. The
number of viable lactic acid bacteria in feces was deter-
mined from the colonies formed on BCP plate count
agar.
Statistical analysis
The results were expressed as the mean and standard
deviation of triple identical assays. A statistical
di#erence in mean was determined by Dunnett’s or
Sche#e’s multiple comparison test after evaluating the
data using Bartlett’s test and Kruskal-Wallis’s test.
Results and Discussion
Figure + shows that the activity of fecal azoreductase
is a#ected by the oral administration of fermented milk
to mice. The fecal azoreductase activity of mice was
suppressed during the consumption of fermented milk.
Even / days after the interruption of administration, a
signiﬁcantly low level of fecal azoreductase activity
was observed. This activity progressively increased
again +* days after the interruption of administration.
However, the resumption of oral administration of
fermented milk repressed the markedly increasing ac-
tivity of fecal azoreductase.
Figure , shows the changes in the activity of fecal
nitroreductase during the experiment period. By the
consumption, interruption and resumption of adminis-
tration of fermented milk to mice, changes in the activ-
ity of fecal nitroreductase similar to those in the
azoreductase activity described above were observed.
Figure - shows the e#ect of consumption of
fermented milk on the number of viable lactic acid
bacteria in feces of mice. It was observed that the
number of viable lactic acid bacteria increased after the
administration of fermented milk, but the increase was
not signiﬁcant. Although the increase continued for /
days after the termination of administration of
fermented milk, the number of bacteria decreased after
that and returned to the initial level prior to the oral
administration of fermented milk.
Plate + shows RAPD patterns of lactic acid bacteria
in feces of mice / days after the oral administration of
fermented milk. L. gasseri JCM ++-* and L.
amylovorus JCM /2++, used for the preparation of
fermented milk, were detected in the feces of mice /
days after the termination of administration.
Azoreductase results in the hydrolysis of
azocompounds such as food dyes. An intermediate
free radical is believed to be formed during the course
of this reductive hydrolysis0. The ﬁnal products of
this reaction are aromatic amines, which can be con-
verted to N-hydroxyl compounds in the intestinal
tract1. Nitroreductase can convert aromatic nitro-
compounds to aromatic amines. Nitroso- and N-
hydroxy compounds are formed during the course of
this reduction2, 3, and they are well-known
Fig. + E#ect of oral administration of fermented milk on azoreductase activity in feces of mice
fed with a high protein and fat diet
The results were expressed as meansstandard deviations of triple identical assays.
The vertical bar represented the standard deviation.
** P*.*+ as compared with group ,. * P*.*/ as compared with group ,.
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carcinogens+*, ++. Bacterial b-glucuronidase and b-
glucosidase are also important in the generation of
toxicants and carcinogens+,, +-. b-Glucuronidase inﬂ-
uences the enterohepatic circulation of carcinogenic
conjugates+.. Azoreductase, nitroreductase and b-
glucuronidase are produced in large amounts by
anaerobic bacteria such as Clostridium bifermentans
and aerobic bacteria such as Escherichia coli, whereas
Lactobacillus strains produce small amounts of these
enzymes+/.
In this study, mice (control mice) in group , fed with
diets of high protein and fat contents exhibited a sig-
niﬁcant increase in the fecal azoreductase and
nitroreductase activities. Administration of fer-
Fig. - Viable counts of lactic acid bacteria in feces of mice
Fig. , E#ect of oral administration of fermented milk on nitroreductase activitiy in feces of mice
fed with a high protein and fat diet
The results were expressed as meansstandard deviations of triple identical assays.
The vertical bar represented the standard deviation.
** P*.*+ as compared with group ,. * P*.*/ as compared with group ,.
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mented milk suppressed the high levels of
azoreductase and nitroreductase activities caused by
feeding of the high protein and fat diet. This result is
in good agreement with the ﬁnding of GOLDIN et al.+, ,
that the rats fed with meat diets exhibited signiﬁcantly
higher levels of fecal azoreductase, nitroreductase and
b-glucuronidase activities as compared with the rats
fed with grain and that the supplementation with L.
acidophilus signiﬁcantly decreased the levels of fecal
azoreductase and nitroreductase activities in meat-
feeding rats. However, ROMOND et al.+0 showed that
the consumption of cell-free concentrated whey from
milk was not related to the decrease in the number of
viable Bacteroides fragilis and Clostridia. These
results revealed that the suppression of fecal
azoreductase and nitroreductase activities was
associated with a partial replacement of the ﬂora with
Lactobacillus strains given by the supplement of
fermented milk.
In this study, the number of viable lactic acid bacte-
ria in feces increased during the administration of
fermented milk and the increase continued for / days
after the termination of administration of fermented
milk. The detection of L. gasseri JCM ++-* and L.
amylovorus JCM /2++ demonstrated that the increase in
the number of viable lactic acid bacteria in feces was
associated with the administration of fermented milk.
However, there was no statistically signiﬁcant increase
in the number of fecal lactic acid bacteria, and the
number of the bacteria decreased +* days after the
termination of administration of fermented milk. The
result revealed that L. gasseri JCM ++-* and L.
amylovorus JCM /2++, which exhibited high adhesional
property to Caco-, cells (human adenocarcinoma,
ATCC HTB -1), did not colonize by adhesion to the
intestinal tract of mice. It was considered that a slight
increase in the number of fecal lactic acid bacteria was
due to the high competition between the administered
lactic acid bacteria and the pre-existing microﬂora or
the replacement of the pre-existing lactic acid bacteria
with the administered lactic acid bacteria.
TANNCOK+1 reported that transient microbes in the
intestinal tract might exert beneﬁcial e#ects without
adhesion to the intestinal cells. The consumption of
L. acidophilus+2 and yoghurt bacteria+3 has been
reported to change the composition of microﬂora in the
feces of humans and rats, respectively.
On the basis of these results, it is reasonable to
conclude that viable lactic acid bacteria in fermented
milk transfer to the intestinal tract and that if they do
not colonize therein, transient lactic acid bacteria in the
intestinal tract repress either the increase of the
number of fecal microﬂora producing large amounts of
azoreductase and nitroreductase or the production of
these enzymes by fecal microﬂora. Our ﬁnding in
mice cannot be directly applied to humans, but L.
gasseri JCM ++-* and L. amylovorus JCM /2++ used for
the preparation of fermented milk could exert bene-
ﬁcial e#ects on the intestinal environment because of
their high adhesional property to Caco-, cells.
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発酵乳がマウス糞便中の発癌関連酵素活性
に及ぼす影響
奈良美環子*古川 徳**松岡昭善**高橋 強**山中良忠**
平成 +,年 2月 ,2日受付平成 +-年 +月 +2日受理
要約 : 腸管内の有害微生物によって生成される糞便中のアゾレダクタゼ及びニトロレダクタゼは 発癌
前駆物質を発癌物質に変換する作用がある 発酵乳の投与がマウス糞便中のこれらの酵素活性に及ぼす影響
について調査した 発酵乳は Lactobacillus gasseri JCM ++-*と Lactobacillus amylovorus JCM /2++をス
タタ菌株として +低脂肪乳に加えて製造した これら ,つの酵素活性はマウスに高蛋白高脂肪食を
与えることにより高くなったが 発酵乳を投与することで非投与群と比較し 有意に低下した さらに マ
ウス糞便中の乳酸菌数は 発酵乳の経口投与により増加し 経口投与終了後でも数日間維持された これら
糞便中に供試乳酸菌株が含まれることを Random ampliﬁed polymorphic DNA ﬁngerprinting RAPD
法によって確認した
キワド : 乳酸菌 糞便 発ガン関連酵素 アゾンレダクタゼ ニトロレダクタゼ
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